Thursday, May 13, 2021 5:46:18 AM
https://finance.yahoo.com/news/widepoint-wyy-report-q1-earnings
Zacks Equity Research
Wed, May 12, 2021, 7:26 PM
WYY
-3.84%
WidePoint Corporation WYY is slated to release first-quarter 2021 results on May 14.
For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $25.45 million, indicating a 35.85% year-over-year plunge.
For the bottom line, the Zacks Consensus Estimate stands at 2 cents, implying a year-over-year decline of 80%.
Notably, the company’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed in the remaining one, the average surprise being 30%.
Let’s see how things have shaped up for this announcement.
Factors at Play
WidePoint’s quarterly revenues are likely to reflect benefits from the 2020 Census project, which is the largest managed mobility services project in the United States.
Material increases on other contracts are also expected to have continued throughout the quarter.
Deal wins, especially from government agencies, are expected to have been a positive for the company.
Moreover, strong demand for WidePoint’s higher-margin revenue streams, including revenues from its managed services business, might have driven growth in adjusted EBITDA during the first quarter.
What Our Model Says
Our proven model does not predict an earnings beat for WidePoint this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
WidePoint currently has a Zacks Rank of 4 (Sell) and an Earnings ESP of 0.00%.
Recent WYY News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 02:07:32 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 10:26:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 05:15:13 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/27/2023 09:41:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 01:31:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 12:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 06:33:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:08:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:59:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:57:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:55:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:53:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:50:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:48:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:45:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:43:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:39:51 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/28/2023 04:55:23 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM